Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
EMBO Molecular Medicine|March 4, 2017
Gene signature driving invasive mucinous adenocarcinoma of the lungMinzhe Guo, Koichi Tomoshige, Michael Meister, et al.
Lung Cancer (Amsterdam, Netherlands)|December 7, 2019
Targeting ROR1 in combination with pemetrexed in malignant mesothelioma cellsNoriko Miyake, Nobuaki Ochi, Hiromichi Yamane, et al.
Cancer Biology & Therapy|January 8, 2013
Antiproliferative effect of a novel mTOR inhibitor temsirolimus contributes to the prolonged survival of orthotopic esophageal cancer-bearing miceToshio Nishikawa, Munenori Takaoka, Toshiaki Ohara, et al.
Oncology Reports|March 6, 2010
RAD001 offers a therapeutic intervention through inhibition of mTOR as a potential strategy for esophageal cancerZhi Gang Wang, Takuya Fukazawa, Toshio Nishikawa, et al.
Oncology Reports|November 21, 2008
TAE226, a dual inhibitor for FAK and IGF-IR, has inhibitory effects on mTOR signaling in esophageal cancer cellsZhi Gang Wang, Takuya Fukazawa, Toshio Nishikawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2011
Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesotheliomaTakafumi Kubo, Shinichi Toyooka, Kazunori Tsukuda, et al.
Plos One|July 9, 2024
Correction: Inhibition of the Growth Factor MDK/Midkine by a Novel Small Molecule Compound to Treat Non-Small Cell Lung CancerHuifang Hao, Yutaka Maeda, Takuya Fukazawa, et al.
Plos One|August 27, 2013
Inhibition of the growth factor MDK/midkine by a novel small molecule compound to treat non-small cell lung cancerHuifang Hao, Yutaka Maeda, Takuya Fukazawa, et al.
Pageof 7